The PCAC will review the available clinical evidence in deciding whether to recommend adding these peptides to the FDA bulk compounding list
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
Quick Recovery : Unlike conventional remedies, which may take hours to show results, IV drips provide immediate relief
Cognitive Support Higher NAD levels activate sirtuins 10 (SIRT1, SIRT3), which protect brain cells by reducing oxidative stress, supporting DNA repair, and improving mitochondrial health
More BAC water = lower concentration = more units for the same dose 10 mg / 1 mL = 10 mg/mL
Admin Reports Admin Reports on Peptides Clinic